Citizens Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.44M | Buy |
3,731
+850
| +30% | +$315K | 0.02% | 361 |
|
|
2026
Q1 | $843K | Sell |
2,881
-454
| -14% | -$149K | 0.01% | 424 |
|
|
2025
Q4 | $1.17M | Sell |
3,335
-79
| -2% | -$26.7K | 0.02% | 367 |
|
|
2025
Q3 | $1.1M | Buy |
3,414
+1,997
| +141% | +$621K | 0.02% | 382 |
|
|
2025
Q2 | $551K | Sell |
1,417
-281
| -17% | -$113K | 0.01% | 453 |
|
|
2025
Q1 | $739K | Buy |
1,698
+19
| +1% | +$7.63K | 0.01% | 356 |
|
|
2024
Q4 | $619K | Sell |
1,679
-985
| -37% | -$412K | 0.01% | 366 |
|
|
2024
Q3 | $1.39M | Buy |
2,664
+328
| +14% | +$175K | 0.03% | 255 |
|
|
2024
Q2 | $1.27M | Buy |
2,336
+890
| +62% | +$470K | 0.03% | 251 |
|
|
2024
Q1 | $750K | Buy |
1,446
+37
| +3% | +$18.4K | 0.03% | 231 |
|
|
2023
Q4 | $664K | Buy |
1,409
+273
| +24% | +$126K | 0.02% | 250 |
|
|
2023
Q3 | $494K | Buy |
1,136
+47
| +4% | +$21.3K | 0.02% | 246 |
|
|
2023
Q2 | $484K | Sell |
1,089
-245
| -18% | -$113K | 0.02% | 276 |
|
|
2023
Q1 | $613K | Sell |
1,334
-203
| -13% | -$96.6K | 0.02% | 266 |
|
|
2022
Q4 | $789K | Buy |
1,537
+34
| +2% | +$17.3K | 0.03% | 215 |
|
|
2022
Q3 | $683K | Sell |
1,503
-26
| -2% | -$12.4K | 0.03% | 228 |
|
|
2022
Q2 | $738K | Sell |
1,529
-68
| -4% | -$33.6K | 0.03% | 227 |
|
|
2022
Q1 | $785K | Buy |
1,597
+116
| +8% | +$53K | 0.03% | 237 |
|
|
2021
Q4 | $653K | Sell |
1,481
-47
| -3% | -$19.8K | 0.02% | 259 |
|
|
2021
Q3 | $570K | Buy |
1,528
+466
| +44% | +$177K | 0.02% | 271 |
|
|
2021
Q2 | $406K | Sell |
1,062
-161
| -13% | -$61.5K | 0.02% | 264 |
|
|
2021
Q1 | $439K | Buy |
1,223
+281
| +30% | +$90.4K | 0.02% | 218 |
|
|
2020
Q4 | $302K | Buy |
+942
| New | +$289K | 0.02% | 232 |
|
|
2020
Q3 | – | Sell |
-1,312
| Closed | -$345K | – | 438 |
|
|
2020
Q2 | $345K | Sell |
1,312
-105
| -7% | -$28K | 0.02% | 217 |
|
|
2020
Q1 | $321K | Buy |
1,417
+54
| +4% | +$14.7K | 0.03% | 220 |
|
|
2019
Q4 | $412K | Buy |
1,363
+533
| +64% | +$147K | 0.03% | 193 |
|
|
2019
Q3 | $199K | Buy |
830
+14
| +2% | +$3.84K | 0.01% | 231 |
|
|
2019
Q2 | $230K | Buy |
816
+299
| +58% | +$81.7K | 0.02% | 217 |
|
|
2019
Q1 | $149K | Buy |
517
+72
| +16% | +$20.8K | 0.01% | 256 |
|
|
2018
Q4 | $117K | Hold |
445
| – | – | 0.01% | 232 |
|
|
2018
Q3 | $122K | Hold |
445
| – | – | 0.01% | 249 |
|
|
2018
Q2 | $106K | Hold |
445
| – | – | 0.01% | 255 |
|
|
2018
Q1 | $98K | Sell |
445
-60
| -12% | -$14.1K | 0.01% | 267 |
|
|
2017
Q4 | $114K | Sell |
505
-25
| -5% | -$5.33K | 0.01% | 268 |
|
|
2017
Q3 | $101K | Hold |
530
| – | – | 0.01% | 283 |
|
|
2017
Q2 | $100K | Sell |
530
-5
| -0.9% | -$898 | 0.01% | 284 |
|
|
2017
Q1 | $88K | Sell |
535
-75
| -12% | -$11.9K | 0.01% | 301 |
|
|
2016
Q4 | $88K | Sell |
610
-40
| -6% | -$5.36K | 0.01% | 306 |
|
|
2016
Q3 | $81K | Sell |
650
-127
| -16% | -$16.4K | 0.01% | 320 |
|
|
2016
Q2 | $102K | Hold |
777
| – | – | 0.01% | 293 |
|
|
2016
Q1 | $108K | Sell |
777
-27
| -3% | -$3.61K | 0.01% | 286 |
|
|
2015
Q4 | $112K | Buy |
+804
| New | +$111K | 0.01% | 287 |
|
Other funds holding ELV
Citizens Financial Group's ELV Position: Q2 2026 in Review
Citizens Financial Group increased its Elevance Health (ELV) stake by 30% in Q2 2026, buying an estimated $315K and bringing the position to 3,731 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #361.
Citizens Financial Group first reported a position in ELV in Q4 2015 and has held it in 42 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Citizens Financial Group held 3,731 shares of Elevance Health worth $1.44M as of Q2 2026.
- Citizens Financial Group bought 850 Elevance Health shares in Q2 2026, an estimated $315K.
- Elevance Health made up 0.02% of Citizens Financial Group's portfolio in Q2 2026, its #361 holding.
- Citizens Financial Group first reported a position in Elevance Health in Q4 2015 and has held it in 42 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Citizens Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.